Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC Directories Mobile Apps Celebrity VCs VentureTrackr Archive About Us
VC-funded Company:

Atox Bio
55 Vilcom Center Drive, Suite 230
Chapel Hill, NC 27514
Phone: 919-636-7260

Atox Bio is a late stage clinical biotechnology company that develops novel immune modulators for critically ill patients with severe infections. Atox Bio has an ongoing contract No. HHSO100201400013 with the Biomedical Advanced Research and Development Authority (BARDA) supporting the development of Reltecimod in NSTI. The Company was established by Prof. Raymond Kaempfer and Dr. Gila Arad from the Hebrew University of Jerusalem and Yissum.

Key Contact
Dan TelemanCEO

Funding Events
12/04/17$30,000,000 Adams Street Partners
Arix Bioscience  
Asahi Kasei
Integra Holdings
Lundbeckfond Ventures
OrbiMed Advisors
SR One
Massinvestor/VC News Daily

© 2017 Massinvestor, Inc.